CD274 and gastric cancer: Studies included assessing MSI, PD-L1, and EBV status in gastric cancer using immunohistochemistry, PCR, or in situ hybridization, and reported outcomes such as overall survival (OS), disease-free survival (DFS), or progression-free survival.